TABLE 3.

Spearman correlations (ρ) between the percentages of IL-12- or TNF-α-producing myeloid DCs or monocytes and the percentages of specific-cytokine-producing or surface marker-expressing T cells for all subjects and separately within the control group and the UTI-prone group

T-cell cytokine/activation marker% IL-12-producing myeloid DCs% TNF-α-producing myeloid DCs% IL-12-producing monocytes% TNF-α-producing monocytes
All subjectsControl groupUTI-prone groupAll subjectsControl groupUTI-prone groupAll subjectsControl groupUTI-prone groupAll subjectsControl groupUTI-prone group
IL-20.210.300.090.190.50b0.070.30a0.210.32−0.08−0.21−0.12
IFN-γ0.080.140.110.41b0.72d0.20−0.06−0.230.010.20−0.060.40a
IL-40.260.390.130.250.44a0.140.260.340.180.39b0.49b0.36a
IL-100.49c0.330.42a0.120.170.270.49c0.290.330.39b0.45a0.34
CD690.43c0.220.54b0.100.200.110.41b0.180.54b0.090.120.04
CD250.46c0.60b0.200.260.270.39a0.46c0.72d0.110.46c0.47a0.43b
CD540.11−0.070.290.170.62c−0.12−0.07−0.340.13−0.10−0.270.06
CD4CD250.2130.456a−0.1180.1250.2400.1450.414c0.3770.3080.020−0.088−0.097
Treg celle0.37b0.60b0.090.230.400.230.46c0.43a0.290.35b0.260.43b
  • a Significant correlation at the 90% confidence level.

  • b Significant correlation at the 95% confidence level.

  • c Significant correlation at the 99% confidence level.

  • d Significant correlation at the 99.9% confidence level.

  • e CD4+ CD25high.